Trial Profile
Prospective, randomized, double-blind study of use of piaglitazone in diabetes mellitus patients and its effect on atrial fibrillation status
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Diabetes mellitus
- Focus Pharmacodynamics
- 01 Dec 2015 New trial record